Obesity. Obesity, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: obese adults of both genders (18-45) with a BMI given as 30-34.9 kg/m2?No weight loss or gain over 2 kg in the recent three months?the samples should have no record of diabetes?cariad disorders?record of angina pectoris, myocardial infarction, cerebral stroke, suffering from renal and hepatic diseases? chronic inflammatory diseases? thyroid diseases and gastroenterological diseases? not consuming hypoglycemic medicines? blood-pressure lowering drugs or anti blood presure medicines? beta blockers? steregene? porgesterone? not consuming any kinds of supplementations such as antioxidant vitamines? minerals? Omega 3 and CLA within two months prior to commencement of study? smoking? using alchoholic drinks? no respiratory or joint complications? not being pregnant or breastfeeding and having no intention for getting pregnant. Moreover, the samples suffering from specific complications such as epigasteric pains will be exclued from this study? The female samples will be excluded from this project in case of pregnancy.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Age. Timepoint: Before Intervention. Method of measurement: Life years from birth based on birth certificate card.;Sex. Timepoint: Before Intervention. Method of measurement: with questionnaire.;Weight. Timepoint: Before Intervention and three months after Intervention. Method of measurement: Kg/scale.;Height. Timepoint: Before Intervention. Method of measurement: Meter/ribor meter.;BMI. Timepoint: Before Intervention and three months after Intervention. Method of measurement: Ratio of weight (kg) to height square (m).;FM%. Timepoint: Before Intervention and three months after Intervention. Method of measurement: Percentage/Body Analyzer.;FFM%. Timepoint: Before Intervention and three months after Intervention. Method of measurement: Percentage/Body Analyzer.;FBS. Timepoint: Before Intervention and three months after Intervention. Method of measurement: Mg/dl/enzymatic method.;Cholesterol. Timepoint: Before Intervention and three months after Intervention. Method of measurement: Mg/dl/enzymatic method.;TG. Timepoint: Before Intervention and three months after Intervention. Method of measurement: Mg/dl/enzymatic method.;VLDL. Timepoint: Before Intervention and three months after Intervention. Method of measurement: Mg/dl/enzymatic method.;LDL. Timepoint: Before Intervention and three months after Intervention. Method of measurement: Mg/dl/enzymatic method.;HDL. Timepoint: Before Intervention and three months after Intervention. Method of measurement: Mg/dl/enzymatic method.;Leptin. Timepoint: Before Intervention and three months after Intervention. Method of measurement: Mg/dl /ELIZA.;Waist Size. Timepoint: Before Intervention and three months after Intervention. Method of measurement: Cm/ribbon meter.;Insulin Resistance. Timepoint: Before Intervention and three months after Intervention. Method of measurement: HOMA-IR (Homeostasis Model Assessment of Insulin Resistance) is the same resistance to insulin index which is calculated as follows. 405/(dl/mg) fasting gluc | — |
Secondary
| Measure | Time frame |
|---|---|
| Gastroenterological side effects. Timepoint: During Intervention. Method of measurement: Taking Report. | — |
Countries
Iran (Islamic Republic of)